from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3547/ddn

LFCtreatmentdescriptionclass of inhibitor

2.455

Amikacinug/mL Amikacintranslation

1.126

Cap5-10ug/mL Capreomycintranslation

0.721

Rox10-50 ug/mL Roxithromycintranslation

1.405

SM2-5 ug/mL Streptomycintranslation

1.679

Tet5-10 ug/mL Tetracyclinetranslation

-0.342

Rif0.2-5ug/mL Rifampicintranscription

-0.315

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.392

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.138

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.299

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.781

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.201

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.189

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.137

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.136

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.058

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.001

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.719

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.370

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.761

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.075

KCN5-20 ug/mL Potassium cyaniderespiration

0.694

NaN30.2-2 mM Sodium aziderespiration

1.574

Nigericin50 uM Nigericinrespiration

-0.899

TRC10-150 ug/mL Triclosanrespiration

-0.080

TRZ10-25 ug/mL Thioridazinerespiration

-1.032

Valinomycin0.5-10 uM Valinomycinrespiration

0.957

ZnSO42 mM ZnSO4respiration

1.119

menadione6-10 ug/mL Menadionerespiration

0.327

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.056

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.481

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.364

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.072

NRP_1Non-replicating persistence stage 1dosRassociated

0.725

Amp0.2mg/mL AmpicillincellWall

0.536

Cephalexin20-100 ug/mL CephalexincellWall

0.210

Cerulenin0.32-5 ug/mL CerulenincellWall

0.186

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.421

EMB10-20 ug/mL EthambutolcellWall

1.393

Eta12-40 ug/mL EthionamidecellWall

1.660

INH0.2-0.4 ug/mL IsoniazidcellWall

0.513

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.716

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.259

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.577

BZA0.12 mg/mL BenzamidearomaticAmides

-0.599

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.646

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.906

H2O24 mM hydrogen peroxideDNAdamaging

0.741

Levo10 ug/mL LevofloxacinDNAdamaging

0.255

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.763

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.430

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.539

UVUV-irradiationDNAdamaging

-0.233

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.138

Antimycin12.5-50 ug/mL Antimycin A?

0.365

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.613

PA_110-50 ug/mL Antitubercular compound PA-1?

0.514

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.597

PA8240.2-2 ug/mL PA-824?

-1.613

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.553

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.551

Verapamil50 uM Verapamil?

0.308

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.192

methoxatin10-20 ug/mL Methoxatin?